TakeoverPE & activists

USPHU S PHYSICAL THERAPY INC /NV

Services-Health Services · $1.1B market cap · 7,294 employees

5.4×

More likely than average to be taken private

Top 1% of the Russell 3000 for a buyout by a private-equity firm, holdco or insiders. How it works

Takeover signals

What an activist or buyer would see: cheap, overpaid, diluted or under pressure.

10 other checks
  • High CEO pay despite TSRNo
    $4M median
    Median CEO pay ≥ $15M while TSR trails
  • Earnings not backed by cashNo
    190% of net income
    Cash flow under 80% of net income
  • Dilutive SBCNo
    1% of revenue
    Over 10% of revenue
  • Payouts exceed cash flowNo
    44% of cash flow
    Buybacks + dividends over cash flow
  • Shareholder dissentNo
    94% lowest support
    Any vote under 80% support
  • Quiet on AINo
    0.7 per 10K words · 28th pct
    Bottom quartile of AI mentions in 10-Ks
  • Net cashNo
    1.8× EBITDA net debt
    More cash than debt, positive EBITDA
  • Recurring revenueNo
    6 of 10
    10-K business scored 7+ of 10 for recurring revenue
  • Active 13DNo
    0 filings
    Active-intent 13D in 18 months
  • Net insider sellingNo
    −$173K net
    Net sales over $10M in 12 months

Key numbers

Revenue
$781MFY2021: $495MFY2022: $553MFY2023: $605MFY2024: $671MFY2025: $781M
16% YoY
Operating margin
11.1%FY2021: 14.3%FY2022: 10.3%FY2023: 8.4%FY2024: 9.4%FY2025: 11.1%
18% YoY
EBITDA
$109MFY2021: $82MFY2022: $72MFY2023: $66MFY2024: $82MFY2025: $109M
34% YoY
Net debt / EBITDA
1.8×
$195M net debt

Financials

MetricFY2021FY2022FY2023FY2024FY2025YoYTrend
Revenue$495M$553M$605M$671M$781M 16% FY2021: $495MFY2022: $553MFY2023: $605MFY2024: $671MFY2025: $781M
Operating income$71M$57M$51M$63M$87M 38% FY2021: $71MFY2022: $57MFY2023: $51MFY2024: $63MFY2025: $87M
Net income$41M$32M$28M$31M$40M 26% FY2021: $41MFY2022: $32MFY2023: $28MFY2024: $31MFY2025: $40M
Operating cash flow$76M$59M$82M$75M$75M 0.2% FY2021: $76MFY2022: $59MFY2023: $82MFY2024: $75MFY2025: $75M
Capex$8M$8M$9M$9M$14M 53% FY2021: $8MFY2022: $8MFY2023: $9MFY2024: $9MFY2025: $14M
Stock-based comp$8M$7M$7M$8M$8M 5.7% FY2021: $8MFY2022: $7MFY2023: $7MFY2024: $8MFY2025: $8M
Buybacks——$0$0$6MFY2023: $0FY2024: $0FY2025: $6M
Dividends$19M$21M$24M$27M$27M 3.1% FY2021: $19MFY2022: $21MFY2023: $24MFY2024: $27MFY2025: $27M

13D filers

None on file.

Insider trading

−$173Knet selling by insiders, open market, last 12 months
Bought $325K · 5 tradesSold $499K · 5 trades

Pay vs performance

YearCEO total compComp actually paidTSR (indexed)Peer TSR
FY2025$4M$4M65134
FY2024$4M$4M74121
FY2023$3M$4M77121
FY2022$2M$2M67117
FY2021$4M$3M79121